Coronary Artery Disease Archives

Does selenium status affect biomarkers of inflammation in patients with coronary artery disease?

In a 2026 Norwegian study, researchers examined and compared epicardial adipose tissue biopsies from two groups of heart disease patients [Opstad 2026]:

Coronary artery disease patients undergoing coronary artery bypass grafting (n = 52)
Heart valve disease patients receiving valve replacement (n = 22)
The heart valve disease patients had lower vulnerability to elevated inflammation levels. As such, they served as a control group to the group of coronary artery disease patients.

The research team obtained the epicardial adipose tissue biopsies during open-chest heart surgery. They measured selenium concentrations in the blood circulation and in the epicardial adipose tissue of the heart disease patients.

Epicardium and epicardial adipose tissue

Note: What is the epicardium?

The Cleveland Clinic explains that the epicardium is the outer layer of the heart muscle and the inner layer of the pericardium that surrounds the heart. A layer of fat (= adipose tissue) separates the epicardium from the heart muscle. The epicardium protects the heart and helps the heart function [Cleveland Clinic staff 2025]. read more

Milestones in early selenium research

1817 Swedish chemist Jöns Jakob Berzelius discovers selenium

1957 Biochemist Klaus Schwarz shows that selenium in microscopic amounts has a vital importance for mammalian health

1969 Professor J.T. Rotruck discovers that selenium has a biochemical role as a component of the antioxidant enzyme glutathione peroxidase

1969 Professors R.J. Shamberger and D.V. Frost report a possible protective effect of selenium against cancer in humans

1973 Professor J.T. Rotruck identifies the enzyme glutathione peroxidase as a selenium-dependent protein

1977 Professor G.N. Schrauzer publishes cancer mortality correlation studies showing an inverse correlation between dietary intakes of selenium and cancer mortality in 27 countries

1988 Professor G.Q Yang summarizes the lessons learned about the selenium-related endemic diseases Keshan disease and Kashin-Beck disease and about the importance of adequate daily selenium intakes

1989 Professor G.G. Duthie publishes evidence for a role of selenium in the prevention of cardiovascular disease

1993 Researcher W.J. Blot publishes the results of the Nutrition Intervention Trials in Linxian, China, showing that supplementation with a combination of selenium and other antioxidants reduces the risk of cancer

1994 Professor G.N. Schrauzer publishes evidence that selenium is important in the maintenance and therapy of HIV-infected patients

1996 Professor Larry Clark publishes the results of a randomized controlled trial – the Nutritional Prevention of Cancer study -- that shows selenium's cancer-protective effects on colon cancer, lung cancer, and prostate cancer

1997 Professor G.F. Combs summarizes the evidence for the protective effects of selenium against cancer

1999 Professor J.E. Oldfield publishes his Selenium World Atlas, mapping areas of selenium deficiency around the world

2000 Researcher O.A. Levander publishes evidence showing an anti-viral effect of selenium

2002 Researcher R. Gärtner shows that supplementation with selenium reduces inflammation in patients with autoimmune thyroiditis

2002 Researcher Margaret Rayman presents the arguments for increasing selenium intakes to realize selenium’s antioxidant and anti-viral and anti-inflammatory effects as well as selenium’s enhancement of immune function and reproductive success.

Tag: Coronary Artery Disease

Selenium and Inflammation in Coronary Artery Disease

Does selenium status affect biomarkers of inflammation in patients with coronary artery disease?

Epicardium and epicardial adipose tissue